Literature DB >> 20627384

Aberrant microRNA expression pattern in myelodysplastic bone marrow cells.

Kais Hussein1, Katharina Theophile, Guntram Büsche, Brigitte Schlegelberger, Gudrun Göhring, Hans Kreipe, Oliver Bock.   

Abstract

The microRNA/miR system might contribute to deregulation of cell homeostasis/disease phenotype. This is the first approach to generate an expression profile of 365 microRNAs in myelodysplastic syndromes (MDS) with normal karyotype (n=12) and distinct cytogenetic aberrations (n=12). In MDS-del(5q), a series of microRNAs not in the 5q-region was increased. MicroRNAs encoded on chromosomes 5, 7 and 8 were not differentially expressed in MDS with del(5q), -7 or +8. Evaluation in a larger cohort could confirm the up-regulation of the miR-1 in MDS. These findings provide evidence that MDS-haematopoiesis is distinct in its microRNA-expression pattern from non-neoplastic cells. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627384     DOI: 10.1016/j.leukres.2010.04.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  18 in total

1.  MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia.

Authors:  Yan Guo; Stephen A Strickland; Sanjay Mohan; Shaoying Li; Amma Bosompem; Kasey C Vickers; Shilin Zhao; Quanhu Sheng; Annette S Kim
Journal:  Leuk Lymphoma       Date:  2017-01-13

Review 2.  [Pathobiology of the microRNA system].

Authors:  K Hussein
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

3.  Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome.

Authors:  Michaela Dostalova Merkerova; Zdenek Krejcik; Hana Votavova; Monika Belickova; Alzbeta Vasikova; Jaroslav Cermak
Journal:  Eur J Hum Genet       Date:  2010-12-08       Impact factor: 4.246

4.  Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.

Authors:  Jing Wen; Ying Huang; Hongying Li; Xupai Zhang; Peng Cheng; Donghong Deng; Zhigang Peng; Jun Luo; Weihua Zhao; Yongrong Lai; Zhenfang Liu
Journal:  Int J Hematol       Date:  2017-02-21       Impact factor: 2.490

5.  Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome.

Authors:  Kazuhiro Maki; Ko Sasaki; Yasunobu Nagata; Fusako Nagasawa; Yuka Nakamura; Seishi Ogawa; Kinuko Mitani
Journal:  Int J Hematol       Date:  2014-07-24       Impact factor: 2.490

6.  Transcriptional regulation of miR-10a/b by TWIST-1 in myelodysplastic syndromes.

Authors:  Xiang Li; Feng Xu; ChunKang Chang; John Byon; Thalia Papayannopoulou; H Joachim Deeg; A Mario Marcondes
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

Review 7.  Epigenetic alterations and microRNAs: new players in the pathogenesis of myelodysplastic syndromes.

Authors:  Diamantina Vasilatou; Sotirios G Papageorgiou; George Dimitriadis; Vasiliki Pappa
Journal:  Epigenetics       Date:  2013-05-09       Impact factor: 4.528

Review 8.  The Yin and Yang of microRNAs: leukemia and immunity.

Authors:  Alex Yick-Lun So; Jimmy L Zhao; David Baltimore
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

Review 9.  The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.

Authors:  Azra Raza; Naomi Galili
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

Review 10.  Implication of microRNAs in the pathogenesis of MDS.

Authors:  Jing Fang; Melinda Varney; Daniel T Starczynowski
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.